University of California San Francisco — San Francisco, California

Public research footprint of University of California San Francisco, compiled from the ClinicalTrials.gov public registry.

3,045

Registered studies

950

Active

545

Recruiting now

1,568

Completed

427

Stopped or withdrawn

Most-studied conditions

PDAC - Pancreatic Ductal Adenocarcinoma · Multiple Myeloma · Recurrent Glioblastoma · Pancreatic Cancer

Recently updated registry entries

NCT07062471 — Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System… (Recruiting)
NCT05063565 — TheraSphere With Durvalumab and Tremelimumab for HCC (Active Not Recruiting)
NCT07196748 — A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to… (Recruiting)

Work at University of California San Francisco?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.